Before the Cosmetic Supervision and Administration Regulation (CSAR) was released in China, only sunscreen efficacy and the waterproof efficacy of sunscreens were required to be evaluated in accordance with Safety and Technical Standards for Cosmetics 2015. For other efficacies of cosmetics, there is no mandatory requirement, and the testing methods for ready reference are also limited. Under this background, consumers have no access to the supporting materials of cosmetic’s claimed efficacy, while cosmetic enterprises lack methods to convince consumers.

Responding to this situation, in CSAR, NMPA specifies that cosmetic’s efficacy claims shall be supported by sufficient scientific basis, and requires to publicize the summary of cosmetic efficacy evaluation. Later on April 9, 2021, NMPA issued the finalized Standards for Cosmetic Efficacy Claim Evaluation, rolling out a detailed plan to standardize and guide the evaluation of cosmetic efficacy claims. The implementation of these new requirements reflects China’s increasingly comprehensive supervision on cosmetics. But at the same time, the strict compliance requirements have posed challenges to cosmetic enterprises.

To help cosmetic stakeholders better understand this new compliance requirement, ChemLinked organized this webinar to detail key regulatory points focusing on efficacy claim evaluation, and also introduce the current industry status under the new requirement.

Further Reading:

• News | CSAR Subsidiary Regulations: China Finalizes Standards for Cosmetic Efficacy Claim Evaluation
• News | CSAR Subsidiary Regulations: China Unveils the Cosmetic Classification Rules and Catalogs
• News | China NMPA Extends the Submission Deadline of Certain Cosmetic Documents due to COVID-19 Lockdown
• English Translation | Cosmetic Classification Rules and Catalogs
• English Translation | Standards for Cosmetic Efficacy Claim Evaluation

1. Background

2. Cosmetic Efficacy Claims

2.1 Classification of Claims

2.2 Prohibited Claims

3. Efficacy Claim Evaluation

3.1 Applicable Claims

3.2 Evaluation Basis

3.3 Evaluation Report and Abstract

3.4 Transitional Measures

4. Industry Status

5. Q&A 

*The final outline may be subjected to subtle revision

Contact Us

If you have any questions about this webinar, please contact us at:

EMAIL: contact@chemlinked.com

TEL: +86 (0) 571 8609 4444